HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

H L Vos Selected Research

Hemorrhage

10/2005Cysteine-mutations in von Willebrand factor associated with increased clearance.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


H L Vos Research Topics

Disease

16Venous Thrombosis (Deep-Vein Thrombosis)
10/2012 - 04/2000
8Thrombophilia
10/2012 - 04/2000
7Thrombosis (Thrombus)
03/2008 - 06/2001
5Myocardial Infarction
12/2003 - 02/2000
2Venous Thromboembolism
03/2014 - 10/2001
2Activated Protein C Resistance (APC Resistance)
10/2012 - 04/2002
2Cardiovascular Diseases (Cardiovascular Disease)
11/2010 - 03/2008
2von Willebrand Diseases (von Willebrand's Disease)
05/2006 - 10/2005
2Carcinoma (Carcinomatosis)
03/2001 - 01/2001
2Hypertension (High Blood Pressure)
02/2001 - 02/2000
1Hemorrhage
10/2005
1Pre-Eclampsia (Preeclampsia)
09/2004
1Type 3 von Willebrand Disease
02/2004
1Breast Neoplasms (Breast Cancer)
03/2001
1Neoplasms (Cancer)
03/2001
1Neoplasm Metastasis (Metastasis)
03/2001
1Heart Diseases (Heart Disease)
02/2001

Drug/Important Bio-Agent (IBA)

7Tyr sulfate(1)- enkephalinamide-Leu (LETS)IBA
10/2012 - 04/2000
7Prothrombin (Factor II)IBA
12/2006 - 02/2001
6factor V LeidenIBA
03/2008 - 04/2002
5von Willebrand FactorIBA
05/2006 - 10/2001
5Factor V (Coagulation Factor V)IBA
01/2006 - 04/2000
3Proteins (Proteins, Gene)FDA Link
03/2014 - 02/2000
3Endothelial Protein C ReceptorIBA
03/2014 - 07/2002
3Protein CIBA
10/2012 - 04/2000
3Glycoproteins (Glycoprotein)IBA
11/2010 - 01/2001
3Factor VIII (Coagulation Factor VIII)IBA
02/2005 - 06/2001
2Factor IX (Coagulation Factor IX)FDA LinkGeneric
09/2008 - 06/2001
2Fibrinogen (Factor I)FDA Link
06/2007 - 06/2001
2Cysteine (L-Cysteine)FDA Link
05/2006 - 02/2004
2MucinsIBA
03/2001 - 01/2001
1Sex Hormone-Binding GlobulinIBA
10/2012
1Oral ContraceptivesIBA
10/2012
1Contraceptive Agents (Contraceptives)IBA
10/2012
1Protein Isoforms (Isoforms)IBA
11/2010
1SelectinsIBA
03/2008
1fibrinogen gamma'IBA
06/2007
1Phenylalanine (L-Phenylalanine)FDA Link
05/2006
1DNA (Deoxyribonucleic Acid)IBA
01/2006
1Factor XII (Hageman Factor)IBA
03/2005
1Adrenergic Receptors (Adrenergic Receptor)IBA
02/2005
1ABO Blood-Group SystemIBA
01/2005
1Carboxypeptidase B2 (Thrombin Activatable Fibrinolysis Inhibitor)IBA
09/2004
1Methylenetetrahydrofolate Reductase (NADPH2) (Methylenetetrahydrofolate Reductase)IBA
09/2004
1Plasminogen InactivatorsIBA
09/2004
1Factor XIIIaIBA
09/2004
1Annexin A5IBA
12/2003
1Factor XIII (Coagulation Factor XIII)IBA
09/2003
1N-acetyl-S-(propionamide)cysteineIBA
04/2002
1AntigensIBA
10/2001
1Factor XI (Plasma Thromboplastin Antecedent)IBA
06/2001
1Vitamin KFDA Link
06/2001
1Factor X (Stuart Factor)IBA
06/2001
1LuciferasesIBA
03/2001
1ElementsIBA
03/2001
1Messenger RNA (mRNA)IBA
03/2001
1Mucin-1 (CA 15-3 Antigen)IBA
03/2001
1Estrogens (Estrogen)FDA Link
02/2001
1Progestins (Progestagens)IBA
02/2001
1SaltsIBA
02/2000
1adducinIBA
02/2000

Therapy/Procedure

1Hormone Replacement Therapy (Therapy, Hormone Replacement)
02/2001